Clinical experience with infliximab biosimilar Remsima (CT-P13) in inflammatory bowel disease patients
2016 ◽
Vol 9
(3)
◽
pp. 322-329
◽
2011 ◽
Vol 17
(suppl_1)
◽
pp. S56-S56
2018 ◽
Vol 41
(10)
◽
pp. 629-635
2015 ◽
Vol 13
(9)
◽
pp. 1704-1705
Keyword(s):
Keyword(s):
2018 ◽
Vol 113
◽
pp. S26
2008 ◽
Vol 14
(12)
◽
pp. 1678-1682
◽
2014 ◽
Vol 60
(4)
◽
pp. 951-956
◽
Keyword(s):